Global Cancer Monoclonal Antibodies Market – Market Forecast, Market Trend, Market Research And Opportunity, Size And Share – 2014-2027

Overview

Monoclonal antibodies identifies cancerous cells, bind to proteins on their surface, and stimulate an immune response so are very specific to targets. Various monoclonal antibodies are available in the market and many more are in the clinical trials. With the growing collaborations with institutes and research companies, a very good growth in the market is expected in the near future.

The Global Monoclonal Antibodies are expected to grow at a CAGR of 9.8% during the analysis period, 2017-2027.

Market Dynamics

Drivers

  • Side effects of the existing drugs
  • More specificity of monoclonal antibodies in targeting cancer cells

Restraints

  • Stringent regulatory guidelines
  • Long duration of clinical trials
  • High cost of research and development

Report Key Benefits

datos-market-post-rd1

Market Segments

By Application

  • Breast Cancer
  • Neuroblastoma
  • Hodgkin Lymphoma
  • Gastric Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Ovarian Cancer
  • Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Malignant Ascites
  • Leukemia
  • Melanoma
  • Non-Small Cell Lung Cancer
  • Others

By type

  • Murine Antibodies
  • Fully Humanized Antibodies
  • Chimeric and Humanized Antibodies

By Therapy

  • Immunoliposomes
  • Antibody Directed Enzyme Prodrug Therapy
  • Immunocytokines
  • Immunotoxins
  • Radioimmunotherapy
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • South Africa
    • Middle East
    • Rest of LAMEA

Company Profiles

  • Amgen Inc.
  • Eli Lilly & Co.
  • Merck & Co. Inc.
  • Spectrum Pharmaceuticals
  • Roche Holding
  • GlaxoSmithKline
  • Bristol-Meyer Squibb

Target Audience

  • Monoclonal antibodies manufacturing companies
  • Service providers, dealers, distributors, and suppliers of Monoclonal antibodies
  • Healthcare institutes
  • Research institutes, associations and academicians
  • Market research and consulting firms
Place an Order

Testimonial

Looking for a Market Analysis Report?